Compagnie Lombard Odier SCmA’s Dr. Reddy's Laboratories RDY Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,150	Closed	-$27K	–	605
2018 Q2	$27K	Hold	4,150	–	–	﹤0.01%	503
2018 Q1	$27K	Hold	4,150	–	–	﹤0.01%	503
2017 Q4	$31K	Hold	4,150	–	–	﹤0.01%	523
2017 Q3	$30K	Hold	4,150	–	–	﹤0.01%	575
2017 Q2	$35K	Sell	4,150 -4,150	-50%	-$33.7K	﹤0.01%	563
2017 Q1	$66K	Buy	8,300 +4,150	+100%	+$35.8K	﹤0.01%	506
2016 Q4	$38K	Hold	4,150	–	–	﹤0.01%	641
2016 Q3	$39K	Hold	4,150	–	–	﹤0.01%	711
2016 Q2	$43K	Hold	4,150	–	–	﹤0.01%	687
2016 Q1	$38K	Hold	4,150	–	–	﹤0.01%	755
2015 Q4	$38K	Hold	4,150	–	–	﹤0.01%	727
2015 Q3	$53K	Hold	4,150	–	–	﹤0.01%	600
2015 Q2	$46K	Hold	4,150	–	–	﹤0.01%	653
2015 Q1	$47K	Hold	4,150	–	–	﹤0.01%	793
2014 Q4	$42K	Buy	+4,150	New	+$43.7K	﹤0.01%	645

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Compagnie Lombard Odier SCmA's RDY Position: Q3 2018 in Review

Compagnie Lombard Odier SCmA sold out of Dr. Reddy's Laboratories (RDY) in Q3 2018, closing a stake of 4,150 shares — an estimated $27K sold.

Compagnie Lombard Odier SCmA first reported a position in RDY in Q4 2014 and held it in 15 quarters. The position peaked at $66K in Q1 2017. 125 funds tracked by Wall St. Rank hold RDY as of Q3 2018.

Compagnie Lombard Odier SCmA reported no remaining Dr. Reddy's Laboratories position as of Q3 2018 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 4,150 Dr. Reddy's Laboratories shares in Q3 2018, an estimated $27K.
Compagnie Lombard Odier SCmA first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 15 quarters.
Compagnie Lombard Odier SCmA's Dr. Reddy's Laboratories position peaked at $66K in Q1 2017.
125 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2018.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2018, filed 13 Nov 2018.